Stay updated on KZR-616 in PM and DM Open-label Extension Clinical Trial
Sign up to get notified when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.

Latest updates to the KZR-616 in PM and DM Open-label Extension Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference3%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedDifference0.7%
- Check46 days agoChange DetectedThe webpage has been updated to reflect the latest version of the study protocol for KZR-616, including changes in the study's administration details and the removal of previous descriptions of the study's design and eligibility criteria.SummaryDifference29%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.9%
Stay in the know with updates to KZR-616 in PM and DM Open-label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KZR-616 in PM and DM Open-label Extension Clinical Trial page.